Changing Landscape of Invasive Pneumococcal Disease Serotypes and Antimicrobial Resistance Following Pneumococcal Conjugate Vaccine Introduction in the Middle East and North Africa Region: A Systematic Review

<b>Background/Objectives:</b> Pneumococcal conjugate vaccines (PCVs) have significantly reduced invasive pneumococcal disease (IPD) globally. We conducted a systematic review to assess whether serotype and antimicrobial resistance trends in the Middle East and North Africa (MENA) reflect...

Full description

Bibliographic Details
Published in:	Vaccines
Main Authors:	Zeinab El Zein, Mayse Nasser, Celina F. Boutros, Nadim Tfaily, Lina Reslan, Kawthar Faour, Sarah Merhi, Stephanie Damaj, Mohammad Bahij Moumneh, Tarek Bou Dargham, Nour Youssef, Magda Haj, Samer Bou Karroum, Sarah Khafaja, Aia Assaf Casals, Sarah Chamseddine, Layal Hneiny, Ghassan S. Dbaibo
Format:	Article
Language:	English
Published:	MDPI AG 2025-08-01
Subjects:	<i>Streptococcus pneumoniae</i> invasive pneumococcal disease (IPD) serotype pneumococcal conjugate vaccine (PCV) antimicrobial resistance (AMR) non-susceptibility
Online Access:	https://www.mdpi.com/2076-393X/13/9/923

Similar Items

Pneumococcal serotypes and their association with death risk in invasive pneumococcal disease: a systematic review and meta-analysis
by: Samuel Darkwah, et al.
Published: (2025-05-01)

Serotype 3 pneumococcal pleural empyema: a case report and review of the epidemiology
by: Maja Thoustrup Legardt Johansen, et al.
Published: (2025-12-01)

Epidemiological Impact of Increasing Vaccination Coverage Rate and Re-Vaccination on Pneumococcal Disease in Older Adults in Germany
by: Oluwaseun Sharomi, et al.
Published: (2025-04-01)

Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality
by: Roger E. Thomas
Published: (2021-02-01)

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017
by: Reiko Shimbashi, et al.
Published: (2020-10-01)

Incidence of Hospitalisation and Emergency Department Visits for Pneumococcal Disease in Children, Adolescents, and Adults in Liguria, Italy: A Retrospective Analysis from 2012–2018
by: Matteo Astengo, et al.
Published: (2022-08-01)

Serotype distribution of invasive Pneumococcal disease in a tertiary children’s hospital in Vietnam
by: Hai Thien Do, et al.
Published: (2025-03-01)

Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations?
by: Daniel Jarovsky, et al.
Published: (2023-03-01)

Global distribution and characteristics of pneumococcal serotypes in adults
by: Haruka Maeda, et al.
Published: (2025-12-01)

Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021
by: Mark A. Fletcher, et al.
Published: (2024-07-01)

Intrafamilial Transmission of Pneumococcal Acute Spontaneous Peritonitis
by: Ioanna Papadatou, et al.
Published: (2023-05-01)

Acute organ injury and long-term sequelae of severe pneumococcal infections
by: Katherine L. Kruckow, et al.
Published: (2023-03-01)

International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005
by: Michael G. Bruce, et al.
Published: (2008-01-01)

Streptococcus pneumoniae serotypes and factors associated with antimicrobial resistance in Invasive pneumococcal disease cases in Latvia, 2012–2022
by: Larisa Savrasova, et al.
Published: (2025-03-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children
by: Leigh M. Howard, et al.
Published: (2023-09-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

Effect of Childhood Pneumococcal Conjugate Vaccination on Invasive Disease Serotypes in Serbia
by: Nataša Opavski, et al.
Published: (2024-08-01)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
by: Cornelis H. van Werkhoven
Published: (2017-05-01)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2021-10-01)

Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024
by: King-Pui Florence Chan, et al.
Published: (2025-05-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

Hospital burden of pneumococcal disease in Spain (2016–2022): A retrospective study
by: Ruth Gil-Prieto, et al.
Published: (2025-12-01)

Invasive pneumococcal disease burden in hospitalized adults in Bogota, Colombia
by: Paula O. Narváez, et al.
Published: (2021-10-01)

Vaccination against pneumococcal infections in adults
by: Kozlov R.S., et al.
Published: (2018-02-01)

Epidemiology of Streptococcus pneumoniae serotypes in children before and after pneumococcal vaccination
by: I. N. Protasova, et al.
Published: (2021-12-01)

What do Patients Know About Pneumococcal Vaccine?
by: Fatma Çiftci, et al.
Published: (2017-08-01)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
by: Filippo Ansaldi, et al.
Published: (2020-01-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

Recent progress in pneumococcal protein vaccines
by: Sha Li, et al.
Published: (2023-09-01)

An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population
by: Ann-Charlotte Fridh, et al.
Published: (2024-12-01)

Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq
by: Al-Jumaili A, et al.
Published: (2023-05-01)

Pneumococcal sternoclavicular septic arthritis: A rare manifestation of invasive pneumococcal disease
by: Yongdeok Shin, et al.
Published: (2025-01-01)

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
by: Juan Buades, et al.
Published: (2021-01-01)

Burden of Hospitalizations Related to Pneumococcal Infection in Spain (2016–2020)
by: Ruth Gil-Prieto, et al.
Published: (2023-01-01)

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
by: Yadong A. Cui, et al.
Published: (2017-06-01)

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
by: Maria Deloria Knoll, et al.
Published: (2021-04-01)

Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment
by: Choon How How, et al.
Published: (2016-09-01)

Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine
by: Antoni Payeras, et al.
Published: (2015-04-01)